Your browser is no longer supported. Please, upgrade your browser.
SLP Simulations Plus, Inc. daily Stock Chart
Simulations Plus, Inc.
Index- P/E122.86 EPS (ttm)0.50 Insider Own27.20% Shs Outstand17.64M Perf Week6.83%
Market Cap1.09B Forward P/E104.75 EPS next Y0.59 Insider Trans-2.92% Shs Float12.90M Perf Month24.35%
Income9.20M PEG8.19 EPS next Q0.10 Inst Own55.00% Short Float13.81% Perf Quarter80.44%
Sales37.70M P/S28.83 EPS this Y14.20% Inst Trans5.39% Short Ratio7.41 Perf Half Y116.46%
Book/sh2.32 P/B26.64 EPS next Y53.25% ROA19.50% Target Price50.25 Perf Year112.30%
Cash/sh0.69 P/C89.10 EPS next 5Y15.00% ROE23.80% 52W Range26.00 - 62.24 Perf YTD112.59%
Dividend0.24 P/FCF201.31 EPS past 5Y20.90% ROI23.00% 52W High-0.71% Beta-0.14
Dividend %0.39% Quick Ratio4.50 Sales past 5Y24.30% Gross Margin73.70% 52W Low137.69% ATR3.29
Employees107 Current Ratio4.50 Sales Q/Q21.20% Oper. Margin29.90% RSI (14)72.52 Volatility4.60% 5.79%
OptionableYes Debt/Eq0.00 EPS Q/Q0.70% Profit Margin24.30% Rel Volume0.79 Prev Close61.17
ShortableYes LT Debt/Eq0.00 EarningsJul 09 AMC Payout46.10% Avg Volume240.38K Price61.80
Recom2.00 SMA2014.31% SMA5032.81% SMA20066.41% Volume190,083 Change1.03%
Jan-06-20Initiated Craig Hallum Buy $40
Jul-05-20 10:52PM  
Jul-02-20 08:30AM  
Jul-01-20 12:30PM  
Jun-11-20 12:37PM  
May-28-20 08:30AM  
May-27-20 05:48PM  
May-21-20 08:30AM  
May-15-20 10:11AM  
May-13-20 08:30AM  
May-06-20 08:30AM  
Apr-21-20 01:24PM  
Apr-17-20 06:00AM  
Apr-10-20 09:17AM  
Apr-09-20 05:55PM  
Apr-07-20 08:30AM  
Apr-02-20 04:15PM  
Mar-30-20 11:07AM  
Mar-26-20 01:46PM  
Mar-18-20 08:30AM  
Mar-05-20 10:57AM  
Feb-26-20 09:56AM  
Feb-04-20 08:30AM  
Jan-13-20 04:22PM  
Jan-12-20 09:48AM  
Jan-10-20 10:15AM  
Jan-09-20 05:25PM  
Jan-03-20 08:30AM  
Jan-01-20 12:30PM  
Dec-13-19 10:47AM  
Dec-09-19 09:15AM  
Dec-05-19 08:30AM  
Nov-29-19 08:04AM  
Nov-21-19 08:30AM  
Nov-14-19 08:30AM  
Nov-13-19 05:25PM  
Nov-06-19 10:30AM  
Oct-30-19 08:22PM  
Oct-29-19 08:30AM  
Oct-17-19 08:30AM  
Oct-15-19 11:32AM  
Oct-14-19 02:30PM  
Oct-02-19 08:30AM  
Sep-26-19 02:31PM  
Sep-17-19 11:18AM  
Sep-12-19 09:16AM  
Sep-11-19 07:00AM  
Sep-06-19 09:30AM  
Sep-04-19 08:30AM  
Aug-21-19 11:47AM  
Aug-08-19 08:52PM  
Aug-05-19 09:30AM  
Aug-02-19 05:00PM  
Jul-29-19 01:47PM  
Jul-22-19 07:52AM  
Jul-19-19 08:02AM  
Jul-18-19 09:30AM  
Jul-16-19 08:30AM  
Jul-11-19 05:39PM  
Jul-10-19 06:23PM  
Jul-09-19 08:30AM  
Jul-03-19 10:30AM  
Jul-02-19 10:30AM  
Jun-29-19 09:24AM  
Jun-27-19 08:30AM  
Jun-24-19 09:15AM  
Jun-18-19 08:30AM  
Jun-11-19 08:30AM  
Jun-10-19 08:02AM  
May-30-19 02:49PM  
May-21-19 08:30AM  
May-16-19 08:30AM  
May-14-19 08:30AM  
May-09-19 11:09AM  
May-01-19 04:15PM  
Apr-30-19 08:30AM  
Apr-18-19 11:37AM  
Apr-11-19 08:30AM  
Apr-09-19 08:16PM  
Apr-04-19 08:57AM  
Apr-02-19 08:30AM  
Apr-01-19 10:30AM  
Feb-19-19 11:57AM  
Feb-15-19 09:06AM  
Jan-30-19 04:54AM  
Jan-29-19 12:51PM  
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a standalone program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for NCA and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher. In addition, it offers MedChem Studio, a software tool for data mining and designing new molecules; KIWI, a cloud-based Web application to organize, process, maintain, and communicate the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program; DILIsym, a quantitative systems pharmacology software; NAFLDsym, a simulation program for analyzing nonalcoholic fatty liver disease; and RENAsym for investigating and predicting drug-induced or acute kidney injury. Further, the company provides population modeling and simulation contract research services for the pharmaceutical and biotechnology industries; and clinical-pharmacology-based consulting services in support of regulatory submissions. It sells its pharmaceutical/chemistry software to pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies. The company was founded in 1996 and is headquartered in Lancaster, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WOLTOSZ WALTER SDirectorJun 24Sale55.8224,0001,339,6804,803,153Jun 24 09:53 PM
WOLTOSZ WALTER SDirectorMay 22Sale39.3524,000944,4004,827,153May 26 05:36 PM
WOLTOSZ WALTER SDirectorApr 24Sale41.2524,000990,0004,850,772Apr 27 05:08 PM
WOLTOSZ WALTER SDirectorMar 25Sale31.7124,000761,0404,874,772Mar 26 06:42 PM
WOLTOSZ WALTER SDirectorFeb 24Sale36.6924,000880,5604,898,772Feb 26 04:48 PM
WOLTOSZ WALTER SDirectorJan 27Sale33.2624,000798,2404,922,327Jan 28 09:15 PM
WOLTOSZ WALTER SDirectorDec 27Sale34.2524,000822,0004,946,327Dec 27 04:27 PM
WOLTOSZ WALTER SDirectorNov 22Sale34.6724,000832,0805,040,327Nov 26 07:52 PM
KNEISEL JOHN ROBERTCFONov 12Option Exercise6.854,40030,1404,400Nov 13 05:25 PM
WOLTOSZ WALTER SDirectorOct 27Sale33.4524,000802,8005,063,918Oct 28 07:28 PM
WOLTOSZ WALTER SDirectorSep 24Sale35.8624,000860,6405,087,918Sep 25 05:46 PM
Paglia John KennethDirectorAug 06Sale37.8669026,1232,112Aug 06 03:43 PM